Skip to main content
. Author manuscript; available in PMC: 2025 Jul 1.
Published in final edited form as: Clin Gerontol. 2023 Sep 9;47(4):536–543. doi: 10.1080/07317115.2023.2254279

Table 1.

Characteristics of ERPO respondents aged ≥65 years (n = 672), by documented presence (N = 92) or absence (n = 580) of cognitive impairment.

Total n (%) Cognitive impairment n (%) No impairment n (%) P valuea

Age group (years) <0.001
65–74 410 (61.0) 29 (31.5) 381 (65.7)
75–84 201 (29.9) 47 (51.1) 154 (26.6)
85+ 61 (9.1) 16 (17.4) 45 (7.8)
Female 64 (9.5) 8 (8.7) 56 (9.7) 0.348
Race/ethnicityb
White 509 (75.7) 68 (73.9) 441 (76.0) 0.695
Black/African American 46 (6.8) 6 (6.5) 40 (6.9) 1
American Indian/Alaska Native 0 (0.0) 0 (0.0) 0 (0.0) -
Asian 4 (0.6) 0 (0.0) 4 (0.7) 1
Native Hawaiian/Pacific Islander 1 (0.1) 1 (1.1) 0 (0.0) 0.137
Latino/Latina/Latinx/Hispanic 9 (1.3) 1 (1.1) 8 (1.4) 1
Other/Unknown 105 (15.6) 16 (17.4) 89 (15.3) 0.643
Veteran 73 (10.9) 11 (12.0) 62 (10.7) 0.719
Documented mental health/cognitive concernb 553 (82.3) 92 (100.0) 461 (79.5) <0.001
History of psychiatric diagnosis and/or treatment 140 (25.3) 24 (26.1) 116 (25.2) 0.896
Other concern about mental health 316 (57.1) 12 (13.0) 304 (65.9) <0.001
Irrational or erratic behavior 119 (21.5) 28 (30.4) 91 (19.7) 0.026
Impaired from medical illness other than dementia 15 (2.7) 2 (2.2) 13 (2.8) 1
State of petition 0.004
California 95 (14.1) 13 (14.1) 82 (14.1)
Colorado 2 (0.3) 0 (0.0) 2 (0.3)
Connecticut 203 (30.2) 34 (37.0) 169 (29.1)
Florida 234 (34.8) 22 (23.9) 212 (36.6)
Maryland 80 (11.9) 6 (6.5) 74 (12.8)
Washington 58 (8.6) 17 (18.5) 41 (7.1)

Missing data not shown if < 5%.

a

P values from two-sample t tests for continuous variables and Fisher’s exact tests for categorical variables due to small cell sizes.

b

≥1 allowed.